Brief: Decibel Therapeutics Submits IND Application For Phase 1/2 Clinical Trial In Pediatric Patients
20/09/2022 12:26
Sept 20 (Reuters) - Decibel Therapeutics Inc DBTX.O :
* DECIBEL THERAPEUTICS INC - SUBMITTED AN IND APPLICATION TO
FDA
FOR A PHASE 1/2 CLINICAL TRIAL IN PEDIATRIC PATIENTS OF DB-OTO
* DECIBEL THERAPEUTICS INC - EXPECTS TO INITIATE A PHASE 1/2
CLINICAL TRIAL OF DB-OTO IN THE FIRST HALF OF 2023
Source text for Eikon: ID:
Further company coverage: DBTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Decibel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Domo, BlackBerry, Rite Aid
U.S. STOCKS ON THE MOVE-Decibel Therapeutics, Affirm Holdings, Medtronic
Decibel rises on FDA's 'fast-track' tag for hearing-loss therapy
Brief: Decibel Therapeutics Says US Food And Drug Administration Had Granted Fast Track Designation For DB-OTO
Decibel Therapeutics Inc reports results for the quarter ended in June - Earnings Summary